NewLake Capital: My Favorite 11% Dividend Yield Investment

NewLake Capital Partners is presented as a strong-buy income investment with an 11%+ dividend yield, supported by a conservatively leveraged net-cash balance sheet and resilient triple-net-lease cash flows. Annual lease escalators of 2.6% and robust dividend coverage help offset cannabis-sector headwinds and tenant-concentration risk. Potential federal rescheduling of medicinal cannabis to Schedule III and a possible exchange uplisting could re-rate the shares toward an 8%-9% yield, implying roughly 27% upside before dividends.

Analysis

The relevant valuation question is not the stated yield but whether cannabis real-estate cap rates can compress without a corresponding reduction in tenant-credit risk. A federal scheduling change may improve operators' cash taxes and access to banking, but it does not automatically create exchange-listing eligibility, interstate commerce, or broad institutional capital access. For NLCP and IIPR, the rerating path therefore depends more on tenant-level rent coverage, lease renewals, and property re-leasing values than on the initial regulatory headline.

NLCP's smaller portfolio creates a barbell outcome: one tenant impairment can materially change AFFO coverage and force the market to retain a distressed yield, while a clean sequence of rent collections and renewed leases can produce disproportionate multiple expansion because the float is thin. IIPR is the cleaner liquid proxy for the same regulatory/tenant-credit theme, but it likely captures less upside from an idiosyncratic NLCP rerating. The second-order beneficiary of improved cannabis operator liquidity is not necessarily landlords first; stronger operators could fund owned real estate or obtain conventional secured financing, reducing sale-leaseback demand and pressuring future acquisition yields over 6-18 months.

Near term, this is primarily an income/carry setup rather than a catalyst trade. Over the next 1-3 months, monitor any tenant restructuring, deferred-rent disclosure, concentration change, or dividend coverage deterioration; these matter more than policy commentary. A durable valuation reset requires several quarters of independently reported collections and evidence that financing costs for cannabis operators are actually declining.

Key Decisions for Investors

• No new directional position solely on the regulatory narrative; treat Schedule III implementation milestones as alerts until exchange-listing and banking rules are clarified. The key falsifier is no measurable improvement in tenant liquidity or financing spreads within 6-12 months.
• For liquid exposure, consider a modest long IIPR versus short VNQ basket over a 3-6 month horizon only after confirming stable quarterly rent collection and AFFO coverage; the trade isolates cannabis-credit normalization from broad rate-driven REIT beta. Exit if IIPR reports a material tenant default, rent deferral, or guidance reduction.
• For NLCP-specific exposure, use limit orders and size for liquidity risk rather than chasing yield. Add only if the next filing confirms no incremental concentration-driven impairment and the dividend remains covered by recurring cash flow; a 200-300 bp yield compression would create meaningful upside, while a single major tenant issue can overwhelm multiple quarters of distributions.
• Watch cannabis operator credit rather than landlord share prices: widening high-yield spreads, equity stress among major private/public tenants, or renewed state-level price deflation should be treated as leading indicators to reduce cannabis REIT exposure before reported rent problems emerge.